Case | HBS Case Collection | 2002 (Revised from original 2001 version)
by Malcolm S. Salter
Genzyme, a tracking stock pioneer, has used its innovative capital structure as a way to frame and grow its R&D-intensive business. Facing the question of how best to integrate a new acquisition into its tracking stock structure, Genzyme's top management is forced to review how tracking stocks add value to Genzyme, whether this value is sustainable, what future governance and control problems the current structure might present, and how these problems might be best handled. A rewritten version of an earlier note.
Keywords: Integration; Value Creation; Motivation and Incentives; Conflict of Interests; Stocks; Capital Structure; Research and Development; Corporate Governance; Biotechnology Industry;
Citation:
Salter, Malcolm S. "Tracking Stocks at Genzyme (A)." Harvard Business School Case 902-023, December 2002. (Revised from original November 2001 version.)
View Profile »View Publications »
Article | Pediatrics | 2012
Effects of Description of Options on Parental Perinatal Decision-Making
Marlyse F. Haward, Leslie John, John M. Lorenz and Baruch Fischhoff
Keywords: Decision Making; Presentations; Mathematical Methods; Personal Characteristics; Attitudes; Motivation and Incentives; Family and Family Relationships; Value; Health Care and Treatment;
Working Paper | HBS Working Paper Series | 2012
How Short-Termism Invites Corruption—And What to Do About It
Malcolm S. Salter
Keywords: Business and Shareholder Relations; Public Ownership; Performance Expectations; Economy; Crime and Corruption; Ethics; Trust; Financial Services Industry; United States;
Working Paper | HBS Working Paper Series | 2010
Lawful but Corrupt: Gaming and the Problem of Institutional Corruption in the Private Sector
Keywords: Crime and Corruption; Civil Society or Community; Competitive Advantage; Earnings Management; Trust; Law; Performance; Investment Funds; Private Sector; Behavior; Relationships; Goals and Objectives;